Literature DB >> 2055653

The treatment of chronic bacterial prostatitis.

A Pfau1.   

Abstract

Chronic bacterial prostatitis, the most common cause of recurrent urinary tract infections in the male patient, is a clinical entity accurately defined by two essential features: (1) recurrent urinary tract infections and (2) persistence of gram-negative bacteria in the prostatic secretion. Chronic bacterial prostatitis is mainly a bacteriologic diagnosis and, therefore, sequential bacteriologic localization cultures are the only way to correct diagnosis. Thirty-five of 39 patients (90%) with chronic bacterial prostatitis were cured of their disease either by a short-term (14-day) intramuscular kanamycin treatment or a long-term (average of five months) oral co-trimoxazole, pure trimethoprim or ciprofloxacin treatment; selected patients suffering from chronic bacterial prostatitis with an associated pathology such as benign enlargement of the prostate, associated occasionally with infected prostatic calculi, who did not respond to medical therapy alone, were cured by a combined adequate antibacterial and surgical (a modified retropubic prostatectomy) treatment. All the patients were followed up for at least one year and most patients several years following treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2055653     DOI: 10.1007/bf01643689

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  26 in total

1.  The pH of the prostatic fluid in health and disease: implications of treatment in chronic bacterial prostatitis.

Authors:  A Pfau; S Perlberg; A Shapira
Journal:  J Urol       Date:  1978-03       Impact factor: 7.450

2.  The response of prostatic fluid pH in inflammation.

Authors:  N J Blacklock; J P Beavis
Journal:  Br J Urol       Date:  1974-10

3.  Prostatitis. Observations on activity of trimethoprim-sulfamethoxazole in the prostate.

Authors:  E M Meares
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

4.  Trimethoprim diffusion into prostatic and salivary secretions of the dog.

Authors:  J J Granato; D M Gross; T A Stamey
Journal:  Invest Urol       Date:  1973-11

5.  Infection stones of prostate gland. Laboratory diagnosis and clinical management.

Authors:  E M Meares
Journal:  Urology       Date:  1974-11       Impact factor: 2.649

6.  Long-term therapy of chronic bacterial prostatitis with trimethoprim-sulfamethoxazole.

Authors:  E M Meares
Journal:  Can Med Assoc J       Date:  1975-06-14       Impact factor: 8.262

7.  A study of concentrations of trimethoprim-sulphamethoxazole in the human prostate gland.

Authors:  N F Dabhoiwala; A Bye; M Claridge
Journal:  Br J Urol       Date:  1976-02

8.  Chronic bacterial prostatitis: new therapeutic aspects.

Authors:  A Pfau; T Sacks
Journal:  Br J Urol       Date:  1976-08

Review 9.  Prostatitis. A continuing enigma.

Authors:  A Pfau
Journal:  Urol Clin North Am       Date:  1986-11       Impact factor: 2.241

10.  Concentrations of trimethoprim and sulphamethoxazole in the human prostate gland after intramuscular injection.

Authors:  W L Wright; P Larking; C J Lovell-Smith
Journal:  Br J Urol       Date:  1982-10
View more
  8 in total

1.  Fluoroquinolone Antimicrobial Agents in the Treatment of Prostatitis and Recurrent Urinary Tract Infections in Men.

Authors:  F M E Wagenlehner; K G Naber
Journal:  Curr Infect Dis Rep       Date:  2005-01       Impact factor: 3.725

Review 2.  The role of quinolones in the treatment of chronic bacterial prostatitis.

Authors:  K G Naber
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 3.  Surgical therapy of prostatitis: a systematic review.

Authors:  Dominik S Schoeb; Daniel Schlager; Martin Boeker; Ulrich Wetterauer; Martin Schoenthaler; Thomas R W Herrmann; Arkadiusz Miernik
Journal:  World J Urol       Date:  2017-06-13       Impact factor: 4.226

Review 4.  Prostatitis and male pelvic pain syndrome: diagnosis and treatment.

Authors:  Florian M E Wagenlehner; Kurt G Naber; Thomas Bschleipfer; Elmar Brähler; Wolfgang Weidner
Journal:  Dtsch Arztebl Int       Date:  2009-03-13       Impact factor: 5.594

5.  Outcome of antibiotic therapy with ciprofloxacin in chronic bacterial prostatitis.

Authors:  W Weidner; M Ludwig; E Brähler; H G Schiefer
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 6.  Treatment response to conventional and novel therapies in chronic prostatitis.

Authors:  Daniel A Shoskes
Journal:  Curr Urol Rep       Date:  2003-08       Impact factor: 2.862

Review 7.  Fluoroquinolone antimicrobial agents in the treatment of prostatitis and recurrent urinary tract infections in men.

Authors:  F M E Wagenlehner; K G Naber
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 2.862

8.  Aminoglycoside antibiotics for NIH category II chronic bacterial prostatitis: A single-cohort study with one-year follow-up.

Authors:  Vittorio Magri; Emanuele Montanari; Emanuela Marras; Gianpaolo Perletti
Journal:  Exp Ther Med       Date:  2016-08-30       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.